z-logo
Premium
Radiosynthesis of the α4β2 nicotinic acetylcholine receptor ligand: 5‐((1‐[ 11 C]‐methyl‐2‐( S )‐pyrrolidinyl)methoxy)‐2‐chloro‐3‐(( E )‐2‐(2‐fluoropyridin‐4‐yl)vinyl)pyridine
Author(s) -
Ravert Hayden T.,
Zhang Yi,
Horti Andrew,
Dannals Robert F.
Publication year - 2006
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.1064
Subject(s) - chemistry , radiosynthesis , pyridine , yield (engineering) , methyl iodide , nicotinic agonist , ligand (biochemistry) , acetylcholine receptor , nicotinic acetylcholine receptor , iodide , medicinal chemistry , chemical synthesis , nuclear chemistry , radiochemistry , receptor , organic chemistry , in vitro , biochemistry , nuclear medicine , positron emission tomography , materials science , metallurgy , medicine
5‐((1‐[ 11 C]‐methyl‐2‐( S )‐pyrrolidinyl)methoxy)‐2‐chloro‐3‐(( E )‐2‐(2‐fluoropyridin‐4‐yl)‐vinyl)pyridine ([ 11 C]‐FPVC) was synthesized from [ 11 C]‐methyl iodide and the corresponding normethyl precursor. The average time of synthesis, purification, and formulation was 42 min with an average non‐decay‐corrected radiochemical yield of 19%. The average specific radioactivity was 359 GBq/µmol (9691 mCi/µmole) at end of synthesis (EOS). Copyright © 2006 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom